SAN DIEGO, Dec. 07, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that the U.S. Food and Drug Administration (FDA) approved ...
USA: Researchers have found in a new study that Clindamycin phosphate 1.2% / adapalene 0.15% / benzoyl peroxide 3.1% (CAB) ...
Despite being the most common vaginal condition,1 BV symptoms are often mistaken for a yeast infection2 JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN), a global healthcare company with a ...
Clindamycin (as phosphate) 1%. Clindamycin inhibits bacterial protein synthesis by binding to the 23S RNA of the 50S subunit of the ribosome. Clindamycin is predominantly bacteriostatic. Although ...
Credit: Getty Images. Xaciato, a lincosamide antibacterial, is a thermosetting bioadhesive hydrogel containing clindamycin phosphate 2%. The Food and Drug Administration (FDA) has approved Xaciato™ ...
December 1, 2006 — The US Food and Drug Administration (FDA) has approved clindamycin phosphate/tretinoin 1.2%/0.025% gel for the once-daily topical treatment of acne vulgaris in patients aged 12 ...
LAVAL, QC / ACCESS Newswire / August 21, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, today announced that ...
Study results suggest the greatest risk for Clostridioides difficile infection was observed with use of clindamycin while the lowest risk was observed with doxycycline and minocycline. Results of the ...
Clindamycin is an antibiotic used to treat certain infections, such as skin infections. More common side effects of clindamycin include itching, mild diarrhea, abdominal (stomach) pain, and nausea and ...
Clindamycin hydrochloride (Cleocin) is a generic prescription medication used to treat certain infections. Specifically, clindamycin is an antibiotic that may be used to treat certain: respiratory ...
An overview of the combination therapy of clindamycin, benzoyl peroxide, and adapalene. Casey Butrus, PharmD: Hilary, we have some innovation coming along the lines and pipeline for acne. I know there ...